Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1225 of 2228 entries
View as:

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

Phase: N/A Priority: Normal
NCT ID: NCT02248116 Org: User:
Start: 05/31/99 End: - Due: -

Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).

Phase: N/A Priority: Normal
NCT ID: NCT02009761 Org: User:
Start: 12/18/13 End: 04/26/16 Due: 04/26/17

SAFE-CRP: Structural Alterations and Function of Endothelium in Cardiovascular Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT00274105 Org: User:
Start: 03/01/01 End: 10/01/04 Due: 10/01/05

BI 811283 in Combination With Cytarabine in Previously Untreated AML Ineligible for Intensive Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00632749 Org: User:
Start: 05/31/08 End: 03/31/14 Due: 03/31/15

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Phase: N/A Priority: Normal
NCT ID: NCT00153062 Org: User:
Start: 08/31/03 End: - Due: -

BIBF 1120 in Combination With Pemetrexed in Advanced Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00979576 Org: User:
Start: 10/16/09 End: 02/16/15 Due: 02/16/16

Intravenous BI 836826 in Combination With Ibrutinib in Relapsed/Refractory CLL Patients Who Have Been Pre-treated With at Least One Prior Line of Systemic Therapy, and Who Are Eligible for Treatment With Ibrutinib

Phase: N/A Priority: Normal
NCT ID: NCT02759016 Org: User:
Start: 06/23/16 End: 07/09/19 Due: 07/09/20

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01282970 Org: User:
Start: 02/28/11 End: - Due: -

Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT02003573 Org: User:
Start: 01/29/14 End: 05/15/16 Due: 05/15/17

Safety, Tolerability and Pharmacokinetics of Single Rising and Multiple Oral Doses of Telmisartan / Hydrochlorothiazide (HCTZ) in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02262780 Org: User:
Start: 12/01/03 End: - Due: -

A Phase I/II Open Label Extension Study of BIBF 1120 Administered Orally Once or Twice Daily to Establish Safety, Pharmacokinetics and Efficacy in Patients With Advanced Solid Tumours and Clinical Benefit From Previous Therapy With BIBF 1120

Phase: N/A Priority: Normal
NCT ID: NCT00715403 Org: User:
Start: 10/31/04 End: - Due: -

Investigation of the Metabolism and Pharmacokinetics of Ambroxol in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02194257 Org: User:
Start: 10/31/08 End: - Due: -

A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With a Tumour in the Brain That is Positive for DLL3

Phase: N/A Priority: Normal
NCT ID: NCT05916313 Org: User:
Start: 02/21/24 End: 03/30/26 Due: 03/30/27

A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00801294 Org: User:
Start: 07/01/06 End: - Due: -

Single Rising Oral Doses of BI 207127 NA as Powder in the Bottle in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02182388 Org: User:
Start: 01/31/07 End: - Due: -

Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02172417 Org: User:
Start: 07/31/00 End: - Due: -

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT06636656 Org: User:
Start: 12/11/24 End: 06/09/28 Due: 06/09/29

Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259829 Org: User:
Start: 09/30/07 End: - Due: -

Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in Hungary

Phase: N/A Priority: Normal
NCT ID: NCT01971086 Org: User:
Start: 10/31/13 End: 03/31/14 Due: 03/31/15

Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02028780 Org: User:
Start: 01/31/14 End: 08/31/14 Due: 08/31/15

TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switch

Phase: N/A Priority: Normal
NCT ID: NCT01134393 Org: User:
Start: 05/31/10 End: - Due: -

Health-related Quality of Life in Patients on Anticoagulants

Phase: N/A Priority: Normal
NCT ID: NCT03134911 Org: User:
Start: 04/24/17 End: 01/31/18 Due: 01/31/19

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00447902 Org: User:
Start: 03/31/07 End: - Due: -

Observational Study to Evaluate Safety of Idarucizumab in Pediatric Patients

Phase: N/A Priority: Normal
NCT ID: NCT02798107 Org: User:
Start: 05/20/19 End: 05/24/19 Due: 05/24/20

Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02217514 Org: User:
Start: 02/29/08 End: - Due: -